- Home
- KOD vs CHMG Comparison
KOD vs CHMG Comparison
Compare KOD & CHMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOD
- CHMG
- Stock Information
- Founded
- KOD 2009
- CHMG 1833
- Country
- KOD United States
- CHMG United States
- Employees
- KOD N/A
- CHMG N/A
- Industry
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- CHMG Major Banks
- Sector
- KOD Health Care
- CHMG Finance
- Exchange
- KOD Nasdaq
- CHMG Nasdaq
- Market Cap
- KOD 188.9M
- CHMG 224.0M
- IPO Year
- KOD 2018
- CHMG N/A
- Fundamental
- Price
- KOD $3.67
- CHMG $48.92
- Analyst Decision
- KOD Hold
- CHMG Hold
- Analyst Count
- KOD 3
- CHMG 3
- Target Price
- KOD $9.00
- CHMG $55.00
- AVG Volume (30 Days)
- KOD 292.9K
- CHMG 14.0K
- Earning Date
- KOD 08-13-2025
- CHMG 07-17-2025
- Dividend Yield
- KOD N/A
- CHMG 2.59%
- EPS Growth
- KOD N/A
- CHMG N/A
- EPS
- KOD N/A
- CHMG 4.74
- Revenue
- KOD N/A
- CHMG $96,163,000.00
- Revenue This Year
- KOD N/A
- CHMG $11.98
- Revenue Next Year
- KOD N/A
- CHMG $8.47
- P/E Ratio
- KOD N/A
- CHMG $10.41
- Revenue Growth
- KOD N/A
- CHMG 0.44
- 52 Week Low
- KOD $1.92
- CHMG $40.71
- 52 Week High
- KOD $11.60
- CHMG $55.73
- Technical
- Relative Strength Index (RSI)
- KOD 51.01
- CHMG 59.94
- Support Level
- KOD $3.55
- CHMG $43.20
- Resistance Level
- KOD $3.82
- CHMG $48.95
- Average True Range (ATR)
- KOD 0.30
- CHMG 1.65
- MACD
- KOD -0.02
- CHMG 0.06
- Stochastic Oscillator
- KOD 35.00
- CHMG 84.12
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
About CHMG Chemung Financial Corp
Chemung Financial Corp is a bank holding firm. Through its subsidiaries, the company provides various financial services, including demand, savings, and time deposits, commercial, residential, and consumer loans, letters of credit, wealth management services, employee benefit plans, insurance products, mutual funds, and brokerage services, among others. The company's reportable segments are Core Banking, Wealth Management (WMG) services, and Holding company and CFS. Maximum revenue is generated from the Core Banking segment, which derives revenue by attracting deposits from the general public and using such funds to originate different types of loans, and to invest in securities. The Wealth Management (WMG) services segment provides trust and investment advisory services to clients.